Teva Pharmaceutical Industries Limited provided earnings guidance for the year 2022. The company expects revenue to be in range of $15.6 billion to $16.2 billion, operating income to be in the range of $4.2 billion to $4.5 billion and EPS to be in the range of $2.40 to $2.60.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.29 USD | -0.06% | +0.25% | +56.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.03% | 18.46B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited Provides Earnings Guidance for the Year 2022